Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims
JID Innov
.
2023 Mar 24;3(4):100199.
doi: 10.1016/j.xjidi.2023.100199.
eCollection 2023 Jul.
Authors
Markqayne Ray
1
,
Kavita Gandhi
1
,
Keshia Maughn
2
,
Amit G Pandya
3
4
Affiliations
1
Patient & Health Impact, Pfizer Inc, Collegeville, Pennsylvania, USA.
2
STATinMED Research, Plano, Texas, USA.
3
Department of Dermatology, Palo Alto Foundation Medical Group, Sunnyvale, California, USA.
4
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
PMID:
37205303
PMCID:
PMC10186599
DOI:
10.1016/j.xjidi.2023.100199
No abstract available